Presentation
Research in progress at the iMETI is focused on identifying what makes emergent diseases different, on the lessons to be learned from pathophysiological studies on these diseases in terms of understanding new biological functions, and on building new therapeutic strategies.
The iMETI’s work on new therapies involves research into the therapeutic use of somatic stem cells and genetic modifications in these cells.
The research carried out at the Institute of Emerging Diseases and Innovative Therapy is targeted on two disease models – HIV/Emerging Viruses, and Prions. Work is now being oriented towards developing new vaccine-based therapies for HIV infection and studying the recently-discovered links between and prion diseases and Alzheimer’s disease.